FLT3 tyrosine kinase in acute non-lymphoblastic leukemias

QR Code

FLT3 tyrosine kinase in acute non-lymphoblastic leukemias

.

Saved in:

Bibliographic Details
Main Authors:	A. S. Bavykin, M. A. Volkova
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/647
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TOXICITY AND EFFICACY OF TYROSINE KINASE INHIBITORS IN COMBINATION WITH CHEMOTHERAPY IN PATIENT WITH RESISTANT Ph-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (CASE REPORT AND LITERATURE REVIEW)
by: K. I. Zarubina, et al.
Published: (2017-10-01)

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
by: Chen J, et al.
Published: (2025-07-01)

Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)

Molecular genetics monitoring of tyrosine kinase inhibitor therapy for chronic myeloid leukemia
by: S. I. Kutsev, et al.
Published: (2022-11-01)

The Mechanisms of Resistance to Tyrosine Kinase Inhibitor Imatinib Therapy of Chronic Myeloid Leukemia
by: S. I. Kutsev, et al.
Published: (2010-06-01)

Ophthalmological Manifestations in Acute Lymphoblastic Leukemia
by: Mateo, Javier, et al.
Published: (2011)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01)

Features of children temperament with acute lymphoblastic leukemia
by: N. A. Kornetov, et al.
Published: (2016-02-01)

THE HISTORY OF CHRONIC MYELOID LEUKEMIA (CML): FROM ARSENIC TO TYROSINE KINASE INHIBITORS (TKI)
by: Rüdiger Hehlmann
Published: (2025-07-01)

Cost impact of Bruton’s tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia
by: Adam S Kittai, et al.
Published: (2025-01-01)

FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Acute Lymphoblastic Leukemia in Adolescents and Young Adults
by: Ribera, Josep-Maria
Published: (2011)

Multidrug Resistance Mechanism of Acute Lymphoblastic Leukemia
by: Su, Zhaoliang, et al.
Published: (2011)

Blinatumomab in pediatric B-acute lymphoblastic leukemia
by: Yifang Cheng, et al.
Published: (2025-07-01)

FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
by: Libo Yan, et al.
Published: (2025-07-01)

Signaling of Receptor Tyrosine Kinases in the Nucleus
by: Stephenson, Sally-Anne, et al.
Published: (2012)

Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors—Hematological Changes and Correlation with European Leukemia Network Response Criteria
by: Karthik Bommannan, et al.

Hemostasis defects correction in children with acute lymphoblastic leukemia
by: A. S. Roshik, et al.
Published: (2022-11-01)

Acute non-lymphoblastic leukemia: characteristics of cytogenetic anomalies and their influence on clinical course of the disease
by: A. M. Vakulchuk, et al.
Published: (2022-11-01)

Comparison of fragment analysis and PCR electrophoresis methods for the detection of FLT3‑ITD mutations in patients with acute myeloid leukemia
by: I. E. Maslyukova, et al.
Published: (2022-11-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations
by: Jie Yang, et al.
Published: (2025-09-01)

STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

FUNCTIONAL ACTIVITY OF NEUTROPHILS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: T. G. Kadricheva, et al.
Published: (2014-07-01)

Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features
by: O. D. Gurieva, et al.
Published: (2025-05-01)

Treatment of Pediatric Acute Lymphoblastic Leukemia and Recent Advances
by: Chang, Tai-Tsung, et al.
Published: (2011)

Mechanism of action of decitabine in treating acute lymphoblastic leukemia
by: Xiaohui Gao, et al.
Published: (2025-07-01)

Relapsed acute lymphoblastic leukemia: back to the drawing board
by: Elad Jacoby
Published: (2025-07-01)

INVESTIGATION OF POSTURAL CONTROL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Fulya Ipek-Erdem, et al.
Published: (2025-07-01)

HOW I TREAT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA
by: Robin Foà
Published: (2025-07-01)

Symptomatic non-convulsive status epilepticus in a patient with acute lymphoblastic leukemia (case report)
by: A. Y. Zakharova, et al.
Published: (2022-01-01)

Epigenetic Rewiring of Protein Kinase Signalling in T-Cell Acute Lymphoblastic Leukaemia
by: Claudina A. Pérez-Novo, et al.
Published: (2025-04-01)

Epigenetic Alteration of Receptor Tyrosine Kinases in Cancer
by: Dricu, Anica, et al.
Published: (2012)

Disseminated Mucormycosis in Patient with Acute Lymphoblastic Leukemia (Clinical Case)
by: S. N. Khostelidi, et al.
Published: (2014-09-01)

The Novel Diketopiperazine Derivative, Compound 5-3, Selectively Inhibited the Proliferation of FLT3-ITD Mutant Acute Myeloid Leukemia (AML) Cells
by: Shijie Bi, et al.
Published: (2025-07-01)

Cardiovascular and metabolic problems associated with application of second generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
by: O. Y. Vinogradova
Published: (2015-10-01)

Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

Thyroid Function Following Treatment of Childhood Acute Lymphoblastic Leukemia
by: Vlachopapadopoulou, Elpis, et al.
Published: (2012)